340 filings
Page 9 of 17
CT ORDER
nvbht egi8miz4enkw
28 Jan 20
Confidential treatment order
11:55am
CT ORDER
boasrctp6pt mj98s
28 Jan 20
Confidential treatment order
11:53am
CT ORDER
hdqtsm6q9
28 Jan 20
Confidential treatment order
11:49am
8-K
vvb7jcdqq8nix3zo
27 Jan 20
Zymeworks Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Over-Allotment Option to Purchase Additional Shares
4:23pm
424B8
120vtt3fhr4runfogujt
27 Jan 20
Prospectus unintentially filed late
6:10am
8-K
t2q7 mkbd2
23 Jan 20
Zymeworks Files Preliminary Prospectus Supplements for Offering of Common
9:44pm
424B5
qs4eb5t
23 Jan 20
Prospectus supplement for primary offering
9:39pm
424B5
30kepw6 y2
21 Jan 20
Prospectus supplement for primary offering
5:29pm
8-K
yvsypyu vh1h
13 Jan 20
Zymeworks Announces Agreement with Pfizer and Initiation of a New Phase 2 Trial
11:20am
8-K
7vrum
7 Jan 20
Zymeworks to Present at the J.P. Morgan Healthcare Conference 2020
4:07pm
8-K
sv47jhb 0g
22 Nov 19
Zymeworks Highlights Advancing Clinical Collaboration with BeiGene and Updated ZW25 Phase 1 Data in HER2-Expressing Cancers at ESMO Asia Congress
4:06pm
8-K
hvcaewn7 dqtx4
18 Nov 19
Zymeworks Announces Selection of ZW25 Abstract for Mini Oral Presentation at the European Society for Medical Oncology Asia (ESMO Asia) Congress
4:07pm
EFFECT
9nw63qi7
8 Nov 19
Notice of effectiveness
12:15am
8-K
abe7 ih9e0
6 Nov 19
Zymeworks Files Automatic Shelf Registration Statement and Enters intoAt-The-Market Equity Offering Sales Agreement
5:16pm
424B5
w64sp7j2d7m3d2ctu
5 Nov 19
Prospectus supplement for primary offering
5:09pm
S-3ASR
g0ek5qdvs24a8td
5 Nov 19
Automatic shelf registration
4:45pm
POS AM
y8t2px29
5 Nov 19
Prospectus update (post-effective amendment)
4:24pm
8-K
y1uhyg0w938svj
5 Nov 19
Zymeworks Reports 2019 Third Quarter Financial Results
12:00am
8-K
931p0czshkb 6li10f
4 Nov 19
Zymeworks to Present at Stifel 2019 Healthcare Conference
4:30pm